beta
(영문) 서울동부지방법원 2014.12.11 2014고단3349

약사법위반

Text

Defendant

A KRW 15 million, Defendant B is punished by a fine of KRW 3 million, and Defendant C is punished by a fine of KRW 4 million.

Reasons

Punishment of the crime

Defendant

A is a business employee in charge of the individual hospital in East Asia, a company in charge of manufacturing and selling prescription drugs, a business employee in charge of the general hospital in East Asia, the defendant Eul, and the defendant C is a business employee in charge of the hospital in East Asia, a drug wholesaler, and a hospital operator in charge of the hospital in East Asia.

No person other than a pharmacy founder may sell drugs or acquire drugs for the purpose of sale.

However, even if the Defendants were not pharmacy founders, they knew that they could easily raise the frymons if they were administered, while they did not detect the doping test, and that they want to illegally purchase the growth fymons by the Bolar players and the healthcare manager, etc. at the hospital in charge of the business of the Defendants, with the knowledge that they would not illegally purchase the growth fymons. As if they ordered the above-mentioned pharmaceutical company where they work as a kind of the growth fymon system, which is a prescription medicine, at the hospital in charge of the business of the Defendants, the Defendants ordered the above-mentioned pharmaceutical company where they worked, and the pharmaceutical company intended to find the hospital and to illegally sell the fymons by receiving it from its doctors without any separate prescription.

1. On June 201, Defendant A received a request from a male on his name, who was aware that the Defendant was not a pharmaceutical company, to purchase the growth Hemon system individually, and received a growth hemon II from a doctor G who operated a management hospital of the Defendant, without any separate medical treatment and prescription in the above manner. On June 26, 2011, Defendant A sold the growth hemon system, which is a prescription drug of KRW 163,786,90,00, in total, 136 times from the above date to March 12, 2014, by receiving KRW 1.2 million from the Defendant’s office located in 64 as Dongdaemun-gu Seoul Dongdaemun-gu, Dongdaemun-gu, Seoul, and sending it to the above part-time.

In this respect.